| Dr Matthew Larsen, DNP, CNM, WHNP-BC | |
|
18077 Outer Hwy 18 Ste 100, Apple Valley, CA 92307-2168 | |
| (760) 946-8169 | |
| (760) 946-8875 |
| Full Name | Dr Matthew Larsen |
|---|---|
| Gender | Male |
| Speciality | Advanced Practice Midwife |
| Location | 18077 Outer Hwy 18 Ste 100, Apple Valley, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932766458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 236034 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
The Boston Globe: The town budget in Framingham, Mass. is strained, leading to layoffs and other cuts. "Everyone here seems to agree that a major factor is the rising cost of health care insurance for employees and retirees, which has jumped by $20 million in 10 years." The town picks up 87 percent of the premiums for most public employees and retirees, as negotiated through collective bargaining.
The Wall Street Journal on Monday examined how many brain injury patients who experience subsequent problems with memory, mental processing or behavior often do not receive cognitive rehabilitation because their health insurers do not cover the treatment.
Under the Hate Crime Statistic Act, hate crimes are defined as "crimes that manifest evidence of prejudice based on race, gender and gender identity, religion, disability, sexual orientation, or ethnicity."
Polynoma LLC, a U.S. oncology-focused biopharmaceutical company within Hong Kong-based CK Life Sciences Int'l., today announced the start of a Phase III clinical trial program for POL 103A, the Company's novel melanoma vaccine. Polynoma's global, multi-center, double-blind, placebo-controlled Melanoma Antigen Vaccine Immunotherapy Study (MAVIS) is designed to enroll a total of 1059 patients with resected Stage IIb, IIc or III melanoma.
The era of one-size-fits-all medicine will eventually be history; after all it is no news that drugs and treatments do not work the same for everyone. For patients with nonsmall cell lung cancer, a lung cancer that kills approximately 1 million people annually, the treatment currently available is basically the same for all patients, despite the fact that some patients may respond to treatment while others may not.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Larsen, DNP, CNM, WHNP-BC 18077 Outer Hwy 18 Ste 100, Apple Valley, CA 92307-2168 Ph: (760) 946-8169 | Dr Matthew Larsen, DNP, CNM, WHNP-BC 18077 Outer Hwy 18 Ste 100, Apple Valley, CA 92307-2168 Ph: (760) 946-8169 |
News Archive
The Boston Globe: The town budget in Framingham, Mass. is strained, leading to layoffs and other cuts. "Everyone here seems to agree that a major factor is the rising cost of health care insurance for employees and retirees, which has jumped by $20 million in 10 years." The town picks up 87 percent of the premiums for most public employees and retirees, as negotiated through collective bargaining.
The Wall Street Journal on Monday examined how many brain injury patients who experience subsequent problems with memory, mental processing or behavior often do not receive cognitive rehabilitation because their health insurers do not cover the treatment.
Under the Hate Crime Statistic Act, hate crimes are defined as "crimes that manifest evidence of prejudice based on race, gender and gender identity, religion, disability, sexual orientation, or ethnicity."
Polynoma LLC, a U.S. oncology-focused biopharmaceutical company within Hong Kong-based CK Life Sciences Int'l., today announced the start of a Phase III clinical trial program for POL 103A, the Company's novel melanoma vaccine. Polynoma's global, multi-center, double-blind, placebo-controlled Melanoma Antigen Vaccine Immunotherapy Study (MAVIS) is designed to enroll a total of 1059 patients with resected Stage IIb, IIc or III melanoma.
The era of one-size-fits-all medicine will eventually be history; after all it is no news that drugs and treatments do not work the same for everyone. For patients with nonsmall cell lung cancer, a lung cancer that kills approximately 1 million people annually, the treatment currently available is basically the same for all patients, despite the fact that some patients may respond to treatment while others may not.
› Verified 5 days ago
Ms. Kimberly Kay Tillotson, CNM/NP Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 18300 Highway 18, Apple Valley, CA 92307 Phone: 760-242-2311 Fax: 760-946-8875 | |
Stephanie Hansen, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 18056 Wika Rd Ste B, Apple Valley, CA 92307 Phone: 760-813-3699 | |
Mrs. Maryam Modirrousta, CNM, NP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 18300 Us Highway 18, Apple Valley, CA 92307 Phone: 706-242-2311 Fax: 760-946-8875 | |
Mrs. Kimberly Sue Deimling-meyer, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 18300 Us Highway 18, Apple Valley, CA 92307 Phone: 760-242-2311 Fax: 760-946-8875 | |
Laurie Roberts, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 18077 Us Highway 18, Suite 100, Apple Valley, CA 92307 Phone: 760-946-8799 Fax: 760-946-8875 |